DRIED ALUMINIUM HYDROXIDE, MAGNESIUM HYDROXIDE & GEL IP

1. Introduction:

Dried Aluminium Hydroxide, Magnesium Hydroxide & Simethicone Gel IP is a pharmaceutical oral suspension formulated to provide relief from acidity, heartburn, acid indigestion, and gastrointestinal discomfort associated with excessive gas formation. This formulation combines two antacid agents with an antiflatulent agent to provide effective symptomatic relief. Each 5 mL contains Dried Aluminium Hydroxide IP 250 mg, Magnesium Hydroxide IP 200 mg, and Simethicone IP 50 mg in a palatable base. Dried Aluminium Hydroxide and Magnesium Hydroxide neutralize excess gastric acid, while Simethicone helps reduce gas-related discomfort by facilitating the breakdown of gas bubbles. The Batch Packing Record (BPR) is an essential GMP document that provides comprehensive information regarding the packaging operations of each manufactured batch. It ensures proper documentation, traceability, product identification, and compliance with established quality standards. The BPR includes packaging material dispensing, line clearance, bottle filling, sealing, labeling, coding, reconciliation, in-process quality checks, and final packaging verification. Proper execution and documentation of packaging activities help prevent product mix-ups, labeling errors, contamination, and packaging defects. The BPR supports regulatory compliance, quality assurance, batch accountability, and the consistent delivery of safe, effective, and quality pharmaceutical products.

Skip to PDF content

2. Flow Diagram for Dried Aluminium Hydroxide, Magnesium Hydroxide & Simethicone Gel IP:

1. Introduction

The Batch Packing Process Flow Diagram illustrates the systematic packaging operations involved in Dried Aluminium Hydroxide, Magnesium Hydroxide & Simethicone Gel IP. The process ensures product quality, packaging integrity, traceability, and compliance with Good Manufacturing Practices (GMP).

2. Bulk Product Receipt and Verification

The process begins with receiving approved bulk gel from the manufacturing department. Product identity, batch details, quantity, and quality status are verified before initiating packaging operations.

3. Packaging Material Dispensing and Line Clearance

Approved packaging materials, including bottles, caps, labels, cartons, and shippers, are dispensed and verified. Line clearance ensures the packaging area is free from previous product materials.

4. Filling, Capping, and Sealing

The gel is filled into suitable containers using calibrated filling equipment. Filling volume, container integrity, cap tightness, and sealing quality are monitored through in-process checks.

5. Labeling and Secondary Packaging

Filled containers undergo labeling, batch coding, cartoning, and shipper packing. Printed information is verified against approved specifications.

6. Reconciliation and Quality Assurance

Packaging materials and finished quantities are reconciled. The completed BPR undergoes Quality Assurance review to confirm compliance before batch disposition.

Conclusion: Proper packaging controls ensure product protection, identification, traceability, and consistent pharmaceutical quality.

3. Critical Process Parameters (CPPs) and Critical Quality Attributes (CQAs) of Dried Aluminium Hydroxide, Magnesium Hydroxide & Simethicone Gel IP:

1. Introduction

Critical Process Parameters (CPPs) and Critical Quality Attributes (CQAs) are essential elements of pharmaceutical quality assurance. Their identification and monitoring help ensure consistent packaging quality, product safety, and compliance with Good Manufacturing Practices (GMP).

2. Critical Process Parameters (CPPs)

CPPs are process variables whose variability can affect critical product quality attributes. Important packaging parameters include:

• Filling Volume: Control of filling machine settings to ensure accurate dispensing.
• Mixing and Agitation: Maintaining product uniformity during filling, where applicable.
• Capping Torque: Controlling closure application to prevent leakage.
• Labeling Accuracy: Verification of product details, batch numbers, and expiry dates.
• Packaging Speed: Maintaining suitable operating conditions for consistent packaging.

3. Critical Quality Attributes (CQAs)

CQAs are measurable product characteristics that must remain within appropriate quality limits.

• Fill Volume: Compliance with approved specifications.
• Product Appearance: Uniform suspension without unacceptable physical changes.
• Container Closure Integrity: Prevention of leakage and contamination.
• Label Accuracy: Correct and legible product information.
• Packaging Integrity: Properly sealed, labeled, and packed containers.

4. Conclusion

Effective monitoring of CPPs and verification of CQAs help minimize packaging defects, maintain batch consistency, and ensure pharmaceutical product quality throughout packaging operations.

Note: Actual CPP classification and acceptance criteria must be justified through product-specific risk assessment and validation.